Blood-based protein biomarkers have recently shown as simpler diagnostic modalities for
colorectal cancer, while their association with clinical pathological characteristics is largely …

Background Although preoperative carcinoembryonic antigen (pre-CEA) and carbohydrate
antigen 19-9 (pre-CA 19-9) are reportedly prognostic indicators for colorectal cancer (CRC) …

In 111 patients with ACC we studied CEA, FP, CA-125 and CA 19.9 during therapy and
follow-up. Marker determination was performed every two months. CEA was elevated (> 5 …

In order to evaluate the usefulness of CA 72-4 tumour-associated antigen assay in colorectal
carcinoma, we have studied 70 patients with benign colorectal diseases and 127 patients …

Background/Aim: To evaluate whether the serum levels of CEA or CA19-9 concentration is a
useful predictor of survival in patients with metastatic colon cancer (mCC). Patients and …

Background In colorectal cancer (CRC) patients, guidelines only recommend measurement
of preoperative carcinoembryonic antigen (CEA), although postoperative CEA may be more …

The clinical significance of preoperative levels of serum carcinoembryonic antigen (CEA)
and carbohydrate antigen 19-9 (CA 19-9) was evaluated in patients with colorectal …

Finding the biomarker or biomarkers with high sensitivity and specificity in colorectal cancer,
and thus a high diagnostic value will determine their clinical usefulness in clinical practice …

BACKGROUND The roles of carcinoembryonic antigen (CEA) and carbohydrate antigen
(CA19-9) in monitoring the patient response to chemotherapy for metastatic colorectal …

Background. This clinicopathological study evaluated the utility of serum carcinoembryonic
antigen (CEA) and carbohydrate antigen (CA) 19-9 as predictors of locoregional recurrence …